2024 Q2 Form 10-Q Financial Statement

#000182646624000063 Filed on May 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $15.80M $18.14M
YoY Change -31.37% -42.0%
Cost Of Revenue $15.81M $18.15M
YoY Change -31.38% -41.99%
Gross Profit -$13.00K -$11.00K
YoY Change -48.0% -21.43%
Gross Profit Margin -0.08% -0.06%
Selling, General & Admin $145.0K $215.0K
YoY Change 10.69% 2.38%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $145.0K $215.0K
YoY Change 10.69% 2.38%
Operating Profit -$158.0K $1.367M
YoY Change -111.29% -1.01%
Interest Expense $1.654M $1.702M
YoY Change 2.8% 0.29%
% of Operating Profit 124.51%
Other Income/Expense, Net
YoY Change
Pretax Income $1.496M $1.476M
YoY Change 2.96% 0.2%
Income Tax
% Of Pretax Income
Net Earnings $1.496M $1.476M
YoY Change 2.96% 0.2%
Net Earnings / Revenue 9.47% 8.14%
Basic Earnings Per Share
Diluted Earnings Per Share $0.10 $0.10
COMMON SHARES
Basic Shares Outstanding 15.49M shares 15.49M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.983M $5.590M
YoY Change -0.99% -13.57%
Cash & Equivalents $296.0K $904.0K
Short-Term Investments $5.687M $4.686M
Other Short-Term Assets $112.0K $97.00K
YoY Change 9.8% 2.11%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $6.095M $5.687M
YoY Change -0.81% -13.35%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $16.24M $16.68M
YoY Change -7.93% -7.41%
Other Assets
YoY Change
Total Long-Term Assets $18.04M $19.41M
YoY Change -8.98% -3.44%
TOTAL ASSETS
Total Short-Term Assets $6.095M $5.687M
Total Long-Term Assets $18.04M $19.41M
Total Assets $24.13M $25.09M
YoY Change -7.04% -5.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $27.00K $6.000K
YoY Change 107.69% -14.29%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $27.00K $6.000K
YoY Change 42.11% -14.29%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $27.00K $6.000K
Total Long-Term Liabilities $0.00
Total Liabilities $27.00K $6.000K
YoY Change 42.11% -14.29%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $24.11M $25.09M
YoY Change
Total Liabilities & Shareholders Equity $24.13M $25.09M
YoY Change -7.04% -5.88%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $1.496M $1.476M
YoY Change 2.96% 0.2%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$44.00K -$311.0K
YoY Change -54.17% 163.56%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $1.915M $1.906M
YoY Change 1.81% 1.87%
Cash From Investing Activities $1.915M $1.906M
YoY Change 1.81% 1.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.479M -$2.788M
YoY Change 14.29% 12.51%
NET CHANGE
Cash From Operating Activities -44.00K -$311.0K
Cash From Investing Activities 1.915M $1.906M
Cash From Financing Activities -2.479M -$2.788M
Net Change In Cash -608.0K -$1.193M
YoY Change 58.33% 64.55%
FREE CASH FLOW
Cash From Operating Activities -$44.00K -$311.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001489874
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
usd
CY2023Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
usd
CY2024Q1 ggro Equity Method Investment Long Term Liabilities
EquityMethodInvestmentLongTermLiabilities
usd
CY2023Q1 ggro Equity Method Investment Long Term Liabilities
EquityMethodInvestmentLongTermLiabilities
usd
CY2024Q1 us-gaap Debt Securities Available For Sale And Held To Maturity Cumulative Unrecognized Loss
DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss
85000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale And Held To Maturity Cumulative Unrecognized Loss
DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss
83000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
12000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
73000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
19000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
64000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18143000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31283000 usd
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Entity File Number
EntityFileNumber
000-53957
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
Golden Growers Cooperative
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MN
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-1312571
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1002 Main Avenue West
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 5
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
West Fargo
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
ND
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
58078
CY2024Q1 dei City Area Code
CityAreaCode
701
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
281-0468
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15490480 shares
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
904000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2097000 usd
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
4686000 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
4548000 usd
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
97000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
318000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
5687000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
6963000 usd
CY2024Q1 us-gaap Debt Securities Noncurrent
DebtSecuritiesNoncurrent
2731000 usd
CY2023Q4 us-gaap Debt Securities Noncurrent
DebtSecuritiesNoncurrent
2788000 usd
CY2024Q1 us-gaap Equity Method Investments
EquityMethodInvestments
16676000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
17073000 usd
CY2024Q1 us-gaap Assets
Assets
25094000 usd
CY2023Q4 us-gaap Assets
Assets
26824000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
421000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
6000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
421000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
6000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
421000 usd
CY2024Q1 us-gaap Limited Partners Capital Account Units Authorized
LimitedPartnersCapitalAccountUnitsAuthorized
60000000000 shares
CY2023Q4 us-gaap Limited Partners Capital Account Units Authorized
LimitedPartnersCapitalAccountUnitsAuthorized
60000000000 shares
CY2024Q1 us-gaap Limited Partners Capital Account Units Issued
LimitedPartnersCapitalAccountUnitsIssued
15490480000 shares
CY2023Q4 us-gaap Limited Partners Capital Account Units Issued
LimitedPartnersCapitalAccountUnitsIssued
15490480000 shares
CY2023Q4 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
15490480000 shares
CY2024Q1 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
15490480000 shares
CY2024Q1 us-gaap Members Capital
MembersCapital
25124000 usd
CY2023Q4 us-gaap Members Capital
MembersCapital
26436000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-36000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-33000 usd
CY2024Q1 us-gaap Members Equity
MembersEquity
25088000 usd
CY2023Q4 us-gaap Members Equity
MembersEquity
26403000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25094000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
26824000 usd
CY2024Q1 us-gaap Revenues
Revenues
18143000 usd
CY2023Q1 us-gaap Revenues
Revenues
31283000 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
18154000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
31297000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1593000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1605000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
215000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
210000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1367000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1381000 usd
CY2024Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
109000 usd
CY2023Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
92000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1476000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1473000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1476000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1473000 usd
CY2024Q1 us-gaap Weighted Average Limited Partnership Units Outstanding
WeightedAverageLimitedPartnershipUnitsOutstanding
15490480 shares
CY2023Q1 us-gaap Weighted Average Limited Partnership Units Outstanding
WeightedAverageLimitedPartnershipUnitsOutstanding
15490480 shares
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Outstanding Limited Partnership And General Partnership Unit Basic And Diluted
IncomeLossFromContinuingOperationsPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDiluted
0.10
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Outstanding Limited Partnership And General Partnership Unit Basic And Diluted
IncomeLossFromContinuingOperationsPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDiluted
0.10
CY2024Q1 us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
1476000 usd
CY2023Q1 us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
1473000 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
5000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1473000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1478000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1476000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1473000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1593000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1605000 usd
CY2024Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-221000 usd
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-212000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-415000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-198000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-311000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-118000 usd
CY2024Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1820000 usd
CY2023Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
58000 usd
CY2024Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
1736000 usd
CY2024Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
1990000 usd
CY2023Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
1929000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1906000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1871000 usd
CY2024Q1 us-gaap Distribution Made To Limited Partner Cash Distributions Paid
DistributionMadeToLimitedPartnerCashDistributionsPaid
2788000 usd
CY2023Q1 us-gaap Distribution Made To Limited Partner Cash Distributions Paid
DistributionMadeToLimitedPartnerCashDistributionsPaid
2478000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2788000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2478000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1193000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-725000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2097000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2146000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
904000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1421000 usd
CY2024Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-3000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
5000 usd
CY2024Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<p id="xdx_809_eus-gaap--BasisOfAccounting_zmm5u5MipqSc" style="text-align: justify"><b>NOTE 1 </b><b>–</b><b> <span id="xdx_82A_zEyOR1NAvGeg">BASIS OF PRESENTATION</span></b> </p> <p style="text-align: justify">The condensed financial statements of Golden Growers Cooperative (the “Cooperative”) for the three-month periods ended March 31, 2024 and 2023 are unaudited and reflect all adjustments consisting of normal recurring adjustments which are, in the opinion of management, necessary for a fair presentation of the financial position and operating results for the interim period. The condensed financial statements should be read in conjunction with the financial statements and notes thereto, contained in the Cooperative’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023. The results of operations for the three-month period ended March 31, 2024 are not necessarily indicative of the results for the entire fiscal year ending December 31, 2024. </p>
CY2024Q1 ggro Annual Payments For Procurement Of Corn And Other Agency Services
AnnualPaymentsForProcurementOfCornAndOtherAgencyServices
60000 usd
CY2024Q1 ggro Number Of Installments
NumberOfInstallments
4 installment
CY2024Q1 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2026-12-31
CY2024Q1 ggro Equity Method Investment Current Assets
EquityMethodInvestmentCurrentAssets
197000 usd
CY2023Q1 ggro Equity Method Investment Current Assets
EquityMethodInvestmentCurrentAssets
209000 usd
CY2023Q4 ggro Equity Method Investment Current Assets
EquityMethodInvestmentCurrentAssets
201000 usd
CY2024Q1 ggro Equity Method Investment Long Term Assets
EquityMethodInvestmentLongTermAssets
33201000 usd
CY2023Q1 ggro Equity Method Investment Long Term Assets
EquityMethodInvestmentLongTermAssets
35840000 usd
CY2023Q4 ggro Equity Method Investment Long Term Assets
EquityMethodInvestmentLongTermAssets
33945000 usd
CY2024Q1 ggro Equity Method Investment Total Assets
EquityMethodInvestmentTotalAssets
33398000 usd
CY2023Q1 ggro Equity Method Investment Total Assets
EquityMethodInvestmentTotalAssets
36049000 usd
CY2023Q4 ggro Equity Method Investment Total Assets
EquityMethodInvestmentTotalAssets
34146000 usd
CY2024Q1 ggro Equity Method Investment Current Liabilities
EquityMethodInvestmentCurrentLiabilities
45000 usd
CY2023Q1 ggro Equity Method Investment Current Liabilities
EquityMethodInvestmentCurrentLiabilities
29000 usd
CY2023Q4 ggro Equity Method Investment Long Term Liabilities
EquityMethodInvestmentLongTermLiabilities
0 usd
CY2024Q1 ggro Equity Method Investment Total Liabilities
EquityMethodInvestmentTotalLiabilities
45000 usd
CY2023Q1 ggro Equity Method Investment Total Liabilities
EquityMethodInvestmentTotalLiabilities
29000 usd
CY2023Q4 ggro Equity Method Investment Total Liabilities
EquityMethodInvestmentTotalLiabilities
0 usd
CY2024Q1 ggro Equity Method Investment Members Equity
EquityMethodInvestmentMembersEquity
33353000 usd
CY2023Q1 ggro Equity Method Investment Members Equity
EquityMethodInvestmentMembersEquity
36020000 usd
CY2023Q4 ggro Equity Method Investment Members Equity
EquityMethodInvestmentMembersEquity
34146000 usd
CY2024Q1 ggro Equity Method Investment Total Liabilities And Members Equity
EquityMethodInvestmentTotalLiabilitiesAndMembersEquity
33398000 usd
CY2023Q1 ggro Equity Method Investment Total Liabilities And Members Equity
EquityMethodInvestmentTotalLiabilitiesAndMembersEquity
36049000 usd
CY2023Q4 ggro Equity Method Investment Total Liabilities And Members Equity
EquityMethodInvestmentTotalLiabilitiesAndMembersEquity
34146000 usd
CY2024Q1 ggro Equity Method Investment Rent Revenue On Operating Lease
EquityMethodInvestmentRentRevenueOnOperatingLease
3952000 usd
CY2023Q1 ggro Equity Method Investment Rent Revenue On Operating Lease
EquityMethodInvestmentRentRevenueOnOperatingLease
3953000 usd
CY2023 ggro Equity Method Investment Rent Revenue On Operating Lease
EquityMethodInvestmentRentRevenueOnOperatingLease
15810000 usd
CY2024Q1 ggro Equity Method Investment Expenses
EquityMethodInvestmentExpenses
766000 usd
CY2023Q1 ggro Equity Method Investment Expenses
EquityMethodInvestmentExpenses
743000 usd
CY2023 ggro Equity Method Investment Expenses
EquityMethodInvestmentExpenses
3641000 usd
CY2024Q1 ggro Equity Method Investment Net Income Loss
EquityMethodInvestmentNetIncomeLoss
3186000 usd
CY2023Q1 ggro Equity Method Investment Net Income Loss
EquityMethodInvestmentNetIncomeLoss
3210000 usd
CY2023 ggro Equity Method Investment Net Income Loss
EquityMethodInvestmentNetIncomeLoss
12169000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale And Held To Maturity Fair Value
DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue
7389000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale And Held To Maturity Fair Value
DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue
7316000 usd
CY2024Q1 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
3867000 usd
CY2024Q1 us-gaap Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
3865000 usd
CY2024Q1 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
2401000 usd
CY2024Q1 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
2392000 usd
CY2024Q1 us-gaap Held To Maturity Securities Debt Maturities After Five Through Ten Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount
330000 usd
CY2024Q1 us-gaap Held To Maturity Securities Debt Maturities After Five Through Ten Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
313000 usd
CY2024Q1 us-gaap Held To Maturity Securities Debt Maturities Single Maturity Date Amortized Cost Basis
HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
6598000 usd
CY2024Q1 us-gaap Held To Maturity Securities Debt Maturities Single Maturity Date Fair Value
HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue
6570000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale And Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
7453000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale And Held To Maturity Cumulative Unrecognized Gain
DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain
21000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale And Held To Maturity Fair Value
DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue
7389000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale And Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
7369000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale And Held To Maturity Cumulative Unrecognized Gain
DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain
30000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale And Held To Maturity Fair Value
DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue
7316000 usd
CY2024Q1 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
1960000 usd
CY2024Q1 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
1561000 usd
CY2023Q4 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
1238000 usd
CY2023Q4 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
1917000 usd
CY2024Q1 us-gaap Defined Benefit Plan Settlements Plan Assets
DefinedBenefitPlanSettlementsPlanAssets
625000 usd
CY2023Q4 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
694000 usd
CY2023Q4 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
680000 usd
CY2022Q4 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
704000 usd
CY2022Q4 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
636000 usd
CY2024Q1 ggro Bushels Of Corn
BushelsOfCorn
15490480
CY2024Q1 ggro Annual Fee Paid For Corn Delivery
AnnualFeePaidForCornDelivery
60000 usd
CY2024Q1 ggro Number Of Installments
NumberOfInstallments
4 installment
CY2024Q1 ggro Incentive Payment Per Bushel To Members On Delivery Of Corn Under Method A
IncentivePaymentPerBushelToMembersOnDeliveryOfCornUnderMethodA
0.05
CY2024Q1 ggro Payment Per Bushel For Corn Delivered Using Method B
PaymentPerBushelForCornDeliveredUsingMethodB
0.02
CY2024Q1 us-gaap General Partners Capital Account Distribution Amount
GeneralPartnersCapitalAccountDistributionAmount
2788286 usd
CY2024Q1 us-gaap Partners Capital Account Distribution Per Unit Of Limited Partner Interest
PartnersCapitalAccountDistributionPerUnitOfLimitedPartnerInterest
0.18
CY2023Q1 us-gaap General Partners Capital Account Distribution Amount
GeneralPartnersCapitalAccountDistributionAmount
2478477 usd
CY2023Q1 us-gaap Partners Capital Account Distribution Per Unit Of Limited Partner Interest
PartnersCapitalAccountDistributionPerUnitOfLimitedPartnerInterest
0.16
CY2024Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
2000000 usd
CY2024Q1 us-gaap Line Of Credit Facility Commitment Fee Percentage
LineOfCreditFacilityCommitmentFeePercentage
0.005 pure
CY2024Q1 us-gaap Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
0.0800 pure
CY2024Q1 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2023Q4 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2024Q1 ggro Annual Payments For Procurement Of Corn And Other Agency Services
AnnualPaymentsForProcurementOfCornAndOtherAgencyServices
60000 usd
CY2024Q1 ggro Number Of Installments
NumberOfInstallments
4 installment
CY2024Q1 us-gaap Significant Supply Commitment Description
SignificantSupplyCommitmentDescription
The agreements between Cargill and the Cooperative terminate concurrently with Cargill’s Second Amended and Restated Facility Lease with ProGold LLC, as amended, which terminates on December 31, 2026.

Files In Submission

Name View Source Status
0001826466-24-000063-index-headers.html Edgar Link pending
0001826466-24-000063-index.html Edgar Link pending
0001826466-24-000063.txt Edgar Link pending
0001826466-24-000063-xbrl.zip Edgar Link pending
exhibit31-1.htm Edgar Link pending
exhibit32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
ggro-20240331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ggro-20240331_def.xml Edgar Link unprocessable
ggro-20240331_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
ggro-20240331_cal.xml Edgar Link unprocessable
ggro-20240331_lab.xml Edgar Link unprocessable